International Flavors & Fragrances Inc. (NYSE: IFF): Corporate Profile & Financials
Source: International Flavors & Fragrances Inc. Form 10-K Fiscal Year 2025
International Flavors & Fragrances Inc. is a global creator and manufacturer of essential inputs used in food, beverage, health, biosciences, scent, and natural health products. Operating across major consumer and end-use categories, the Company holds leading positions in Food & Beverage, Home & Personal Care, and Health & Wellness markets worldwide.
- Health & Biosciences ($2,283): Advanced biotechnology platform developing enzymes, food cultures, probiotics, and specialty ingredients across five units: Health, Food Biosciences, Home & Personal Care, Animal…
- Scent ($2,479): Comprises Fragrance Compounds (Fine Fragrances and Consumer Fragrances including Fabric, Home, and Body Care) and Fragrance Ingredients.
- Pharma Solutions ($369): Produced cellulosic and seaweed-based pharmaceutical excipients before its completed divestiture on May 1, 2025.
📋 Quick Facts / Company Snapshot: International Flavors & Fragrances Inc. (NYSE
| Corporate Metric | Company Disclosure Detail |
|---|---|
| Official Name | International Flavors & Fragrances Inc. |
| Ticker Symbol | IFF |
| Primary Exchange | New York Stock Exchange (NYSE) |
| Principal Executive Offices | 521 West 57th Street, New York, NY 10019-2960 / 200 Powder Mill Road, Wilmington, DE 19803-2907 |
| Industry / Sector | Specialty Chemicals / Flavors, Fragrances, Food Ingredients & Biosciences |
| State of Incorporation | New York |
| Total Employees | Approximately 21,500 worldwide (approximately 5,500 in the United States) |
| Key R&D Facilities | Union Beach (NJ), Wilmington (DE), Palo Alto (CA), Brabrand (Denmark), Leiden (The Netherlands) |
| Patents Portfolio | 849 granted U.S. patents, 451 pending U.S. patent applications, plus thousands globally |
| Principal Subsidiaries | Frutarom Industries Ltd., Nutrition & Biosciences, Inc., Icon Newco Ltd., Neptune Merger Sub I Inc., Neptune Merger Sub II LLC, Solae, LLC |
| Chief Executive Officer | J. Erik Fyrwald |
| Chief Financial Officer | Michael DeVeau |
| IRS Employer ID Number | 13-1432060 |
| Commission File Number | 1-4858 |
| Research & Development Workforce | Approximately 3,000 employees globally |
| Global Facility Footprint | 289 total sites (115 owned, 174 leased) across approximately 30 countries |
| Customer Base | Approximately 20,000 customers globally across multinational and regional markets |
| Auditor | PricewaterhouseCoopers LLP (PCAOB ID: 238) |
| External Website | https://www.iff.com |
1. Corporate Identity: International Flavors & Fragrances Inc. (NYSE Overview & History
The Big Picture
International Flavors & Fragrances Inc. is a global creator and manufacturer of essential inputs used in food, beverage, health, biosciences, scent, and natural health products. Operating across major consumer and end-use categories, the Company holds leading positions in Food & Beverage, Home & Personal Care, and Health & Wellness markets worldwide.
The enterprise supplies a wide array of specialized product formulations including flavor compounds, natural taste solutions, specialty food ingredients, biotech enzymes, food cultures, probiotics, fine fragrances, and consumer fragrance compounds. In fiscal year 2025, International Flavors & Fragrances generated $10.890 billion in consolidated net sales across more than 30 countries.
- Global Footprint: International Flavors & Fragrances conducts business across North America, Europe, the Middle East, Africa, Greater Asia, and Latin America, with U.S. sales representing 28% of total 2025 revenue.
- Broad Market Integration: The Company’s solutions touch thousands of everyday products including dairy, meat, beverages, snacks, baked goods, soaps, detergents, fine perfumes, dietary supplements, animal nutrition, and biofuels.
- High Customer Diversification: Serve approximately 20,000 customers globally, with no individual customer representing 10% or more of consolidated sales in fiscal year 2025.
The Founders & Their Legacy
International Flavors & Fragrances traces its corporate history through a lineage of innovation and strategic combination in the taste, scent, and biotechnology sectors. Incorporated under the laws of the State of New York, the enterprise has grown through historic foundational combinations and major transformational acquisitions, including the merger with Frutarom Industries Ltd. in 2018 and the combination with DuPont’s Nutrition & Biosciences (“N&B”) business in 2021.
The Company maintains dual principal executive headquarters at 521 West 57th Street in New York, New York, and 200 Powder Mill Road in Wilmington, Delaware. These dual centers direct global commercial operations, administrative leadership, scientific innovation, and global supply chain execution.
The Journey: History & Evolution
The Company’s structural footprint reflects significant portfolio transformations over recent years designed to streamline business focus toward core growth categories. Following the transformational N&B transaction in 2021, International Flavors & Fragrances built an expansive enterprise spanning flavors, food ingredients, active cultures, enzymes, fine fragrances, and pharmaceutical excipients.
To optimize its business portfolio and reduce balance sheet leverage, management executed a series of targeted divestitures. In 2023, the Company completed the sales of its Flavor Specialty Ingredients business, a portion of its Savory Solutions business, and the Sonarome entity. In 2024, the Company closed the divestitures of its Cosmetic Ingredients business and its Flavors & Essences UK business.
- 2025 Restructuring: Effective January 1, 2025, the Company restructured its former Nourish segment into two separate reportable operating segments: Taste and Food Ingredients.
- Pharma Solutions Exit: On May 1, 2025, the Company completed the sale of its Pharma Solutions disposal group for $2.581 billion in gross cash proceeds, followed by the sale of its Nitrocellulose business on May 9, 2025 for $161 million.
- Productivity Enhancement: In 2024, management initiated the IFF Productivity Program aimed at optimizing organizational footprint, rationalizing facility usage, and streamlining global headcount through 2026.
The Corporate Umbrella
International Flavors & Fragrances operates as a parent holding company directing dozens of operational, holding, and research subsidiaries around the globe. Primary operating entities include Nutrition & Biosciences, Inc. and Solae, LLC in the United States, Frutarom Industries Ltd. in Israel, and numerous international subsidiaries spanning Europe, Latin America, and Asia.
2. The Business Engine: International Flavors & Fragrances Inc. (NYSE Business Model & Revenue Segments
The Core Divisions
During fiscal year 2025, the Company organized its operations into five reportable business segments: Taste, Food Ingredients, Health & Biosciences, Scent, and Pharma Solutions (until its divestiture in May 2025). Each division targets unique consumer applications and technological platforms.
| Segment Name | 2025 Net Sales ($M) | 2024 Net Sales ($M) | 2023 Net Sales ($M) | 2025 Adj. EBITDA ($M) | 2024 Adj. EBITDA ($M) | 2023 Adj. EBITDA ($M) | Latest YoY (%) |
|---|---|---|---|---|---|---|---|
| Taste | 2,481 | 2,428 | 2,303 | 478 | 460 | 389 | +2.18% |
| Food Ingredients | 3,278 | 3,365 | 3,692 | 423 | 408 | 369 | -2.59% |
| Health & Biosciences | 2,283 | 2,203 | 2,071 | 594 | 577 | 524 | +3.63% |
| Scent | 2,479 | 2,439 | 2,393 | 515 | 545 | 496 | +1.64% |
| Pharma Solutions | 369 | 1,049 | 1,020 | 76 | 215 | 202 | -64.82% |
| Consolidated Total | 10,890 | 11,484 | 11,479 | 2,086 | 2,205 | 1,980 | -5.17% |
The Taste segment develops flavor compounds and natural taste solutions utilized in savory foods (soups, sauces, meats, snacks), beverages (juices, carbonated drinks, spirits), sweets (bakery, candy, cereal, gum), dairy items, and culinary seasonings. The segment delivered 2025 net sales of $2.481 billion and Adjusted Operating EBITDA of $478 million.
The Food Ingredients segment produces natural, artificial, and plant-based specialty food ingredients including soy and pea protein formulations, emulsifiers, sweeteners, natural antioxidants, and anti-microbials for shelf-life extension. In 2025, Food Ingredients generated $3.278 billion in net sales and $423 million in Adjusted Operating EBITDA.
- Health & Biosciences: Advanced biotechnology platform developing enzymes, food cultures, probiotics, and specialty ingredients across five units: Health, Food Biosciences, Home & Personal Care, Animal Nutrition, and Grain Processing. Generated $2.283 billion in 2025 sales.
- Scent: Comprises Fragrance Compounds (Fine Fragrances and Consumer Fragrances including Fabric, Home, and Body Care) and Fragrance Ingredients. Delivered $2.479 billion in 2025 sales and $515 million in Adjusted Operating EBITDA.
- Pharma Solutions: Produced cellulosic and seaweed-based pharmaceutical excipients before its completed divestiture on May 1, 2025. Contributed $369 million in net sales prior to sale closure.
The Global Product Catalog
The Company maintains a massive catalog of specialized ingredients derived from both synthetic chemical synthesis and natural origin. Sourced raw materials include botanical extracts, essential oils, fruits, flowers, marine products, and agricultural crops such as soy, wheat, corn, and pea.
Across its network, the Company processes approximately 20,000 distinct raw materials collected from domestic and international suppliers. Product platforms focus on key consumer wellness themes including low-sugar, high-fiber, lactose-free dairy formulations, bio-based cleaning enzymes, renewable polymers, animal welfare feed enzymes, and long-lasting fragrance delivery systems.
The Names You Know
Because International Flavors & Fragrances operates primarily as a business-to-business supplier, its technologies are incorporated directly into thousands of consumer products manufactured by external brand owners. The Company serves major multinational consumer packaged goods companies, mid-sized regional manufacturers, private-label producers, and emerging consumer brands.
- Customer Concentration: In fiscal year 2025, the Company’s 25 largest customers accounted for approximately 32% of total sales.
- Mid-Sized & Regional Depth: Approximately 69% of fiscal year 2025 sales were generated from small and mid-sized consumer product companies.
- Core Supplier Status: International Flavors & Fragrances maintains presence on the strategic “core supplier lists” of the vast majority of its global consumer goods customers.
Mapping the Global Reach
Commercial revenues are geographically diversified across four primary reporting regions: Europe, Middle East and Africa (EAME), Greater Asia, North America, and Latin America.
| Geographic Region | 2025 Net Sales ($M) | 2024 Net Sales ($M) | 2023 Net Sales ($M) | Latest YoY (%) |
|---|---|---|---|---|
| Europe, Africa and Middle East | 3,727 | 3,840 | 3,834 | -2.94% |
| Greater Asia | 2,546 | 2,731 | 2,677 | -6.77% |
| North America | 3,195 | 3,440 | 3,477 | -7.12% |
| Latin America | 1,422 | 1,473 | 1,491 | -3.46% |
| Consolidated Total | 10,890 | 11,484 | 11,479 | -5.17% |
By specific geographic origin, net sales related to the United States totaled $3.075 billion in 2025, $3.219 billion in 2024, and $3.185 billion in 2023. Sales attributed to all foreign countries combined reached $7.815 billion in 2025, representing approximately 72% of consolidated net sales. No single country outside the United States accounted for 10% or more of total annual sales.
The Brick & Mortar Footprint
As of December 31, 2025, the Company operated 289 facilities spanning manufacturing plants, creative centers, application laboratories, offices, and distribution centers across approximately 30 countries.
| Facility Type | Owned (EAME) | Leased (EAME) | Owned (NA) | Leased (NA) | Owned (Asia) | Leased (Asia) | Owned (LatAm) | Leased (LatAm) | Total Owned | Total Leased |
|---|---|---|---|---|---|---|---|---|---|---|
| Plants | 37 | 12 | 17 | 7 | 19 | 4 | 13 | 3 | 86 | 26 |
| Offices | 1 | 43 | 0 | 2 | 1 | 12 | 0 | 2 | 2 | 59 |
| Laboratories | 3 | 16 | 2 | 11 | 2 | 19 | 1 | 6 | 8 | 52 |
| Warehouses | 2 | 15 | 0 | 7 | 0 | 3 | 1 | 4 | 3 | 29 |
| Other Sites | 7 | 1 | 0 | 4 | 7 | 2 | 2 | 1 | 16 | 8 |
| Regional Total | 50 | 87 | 19 | 31 | 29 | 40 | 17 | 16 | 115 | 174 |
Major international manufacturing centers are operated in the Netherlands, Spain, Germany, Indonesia, Turkey, Brazil, Mexico, Slovenia, China, India, Ireland, Norway, Finland, Denmark, Belgium, and Singapore.
3. The Financial Health: International Flavors & Fragrances Inc. (NYSE (FY 2025) Audited Financial Statements
Earnings, Expenses & Profits: International Flavors & Fragrances Inc. (NYSE Income Statement
Consolidated Net Sales for fiscal year 2025 reached $10.890 billion, compared to $11.484 billion in 2024 and $11.479 billion in 2023. The reported top-line decline in 2025 reflected the impact of business divestitures amounting to approximately $757 million, partially offset by comparable volume increases and pricing gains.
| Line Item (in $ millions) | 2025 | 2024 (Restated) | 2023 (Restated) | Latest YoY (%) |
|---|---|---|---|---|
| Net sales | 10,890 | 11,484 | 11,479 | -5.17% |
| Cost of sales | 6,952 | 7,360 | 7,798 | -5.54% |
| Gross profit | 3,938 | 4,124 | 3,681 | -4.51% |
| Research and development expenses | 694 | 671 | 636 | +3.43% |
| Selling and administrative expenses | 1,834 | 1,995 | 1,787 | -8.07% |
| Restructuring and other charges | 70 | 29 | 68 | +141.38% |
| Amortization of acquisition-related intangibles | 568 | 610 | 680 | -6.89% |
| Impairment of goodwill | 1,153 | 64 | 2,623 | +1701.56% |
| Losses (Gains) on sale of assets | 1 | (11) | (3) | N/M |
| Operating (loss) profit | (382) | 766 | (2,110) | N/M |
| Interest expense | 229 | 305 | 380 | -24.92% |
| Gain on extinguishment of debt | (488) | 0 | 0 | N/M |
| Losses (Gains) on business disposals | 109 | (346) | 23 | N/M |
| Loss on assets classified as held for sale | 115 | 317 | 0 | -63.72% |
| Other expense, net | 65 | 182 | 5 | -64.29% |
| (Loss) income before taxes | (412) | 308 | (2,518) | N/M |
| (Benefit) Provision for income taxes | (53) | 41 | 69 | N/M |
| Net (loss) income | (359) | 267 | (2,587) | N/M |
| Net income attributable to non-controlling interest | 2 | 4 | 4 | -50.00% |
| Net (loss) income attributable to IFF shareholders | (361) | 263 | (2,591) | N/M |
Gross profit for 2025 stood at $3.938 billion, representing a gross margin of 36.2%, compared to $4.124 billion (35.9% gross margin) in 2024 and $3.681 billion (32.1% gross margin) in 2023. Gross profit expansion over the three-year period was bolstered by cost reduction, productivity gains, and lower raw material input costs.
The Company reported an operating loss of $(382) million in 2025, driven by a non-cash goodwill impairment charge of $1.153 billion associated with the Food Ingredients reporting unit following the segment reorganization on January 1, 2025. In 2024, operating profit was $766 million, while 2023 experienced an operating loss of $(2.110) billion due to a $2.623 billion goodwill impairment in the former Nourish segment.
- Debt Extinguishment Gain: In May 2025, the Company completed cash tender offers for outstanding senior notes, capturing a pre-tax gain on debt extinguishment of $488 million.
- Income Tax Realignment Benefit: Provision for income taxes in 2025 was a benefit of $(53) million, incorporating a $360 million tax benefit recognized from a multi-phase corporate legal entity realignment project.
- Net Loss: Net loss attributable to International Flavors & Fragrances Inc. shareholders was $(361) million in 2025, compared to net income of $263 million in 2024 and a net loss of $(2.591) billion in 2023.
Assets, Debts & Equity: International Flavors & Fragrances Inc. (NYSE Balance Sheet
The Consolidated Balance Sheet reflects significant capital structure changes resulting from asset sales, debt reduction, and long-lived asset valuations.
| Line Item (in $ millions) | 2025 | 2024 (Restated) | Latest YoY (%) |
|---|---|---|---|
| Cash, cash equivalents, and restricted cash | 590 | 469 | +25.80% |
| Trade receivables (net of allowances) | 1,731 | 1,624 | +6.59% |
| Inventories | 2,245 | 2,133 | +5.25% |
| Assets held for sale | 151 | 3,056 | -95.06% |
| Prepaid expenses and other current assets | 877 | 686 | +27.84% |
| Total Current Assets | 5,594 | 7,968 | -29.79% |
| Property, plant and equipment, net | 4,029 | 3,739 | +7.76% |
| Goodwill | 8,269 | 9,075 | -8.88% |
| Other intangible assets, net | 6,043 | 6,445 | -6.24% |
| Operating lease right-of-use assets | 579 | 589 | -1.70% |
| Other assets | 1,025 | 907 | +13.01% |
| Total Assets | 25,539 | 28,723 | -11.09% |
| Short-term debt and current portion of long-term debt | 1,254 | 1,413 | -11.25% |
| Accounts payable | 1,287 | 1,283 | +0.31% |
| Accrued payroll and bonus | 327 | 420 | -22.14% |
| Dividends payable | 102 | 102 | 0.00% |
| Liabilities held for sale | 44 | 332 | -86.75% |
| Other current liabilities | 919 | 802 | +14.59% |
| Total Current Liabilities | 3,933 | 4,352 | -9.63% |
| Long-term debt | 4,740 | 7,564 | -37.33% |
| Total Debt (Short-term + Long-term) | 5,994 | 8,977 | -33.23% |
| Retirement liabilities | 186 | 167 | +11.38% |
| Deferred income taxes | 1,379 | 1,594 | -13.49% |
| Operating lease liabilities | 533 | 550 | -3.09% |
| Other liabilities | 582 | 627 | -7.18% |
| Total Other Liabilities | 7,420 | 10,502 | -29.35% |
| Total Liabilities | 11,353 | 14,854 | -23.57% |
| Common stock | 35 | 35 | 0.00% |
| Capital in excess of par value | 19,918 | 19,917 | +0.01% |
| Accumulated deficit | (3,417) | (2,647) | +29.09% |
| Accumulated other comprehensive loss | (1,430) | (2,527) | -43.41% |
| Treasury stock, at cost | (952) | (944) | +0.85% |
| Total Shareholders’ Equity | 14,154 | 13,834 | +2.31% |
| Non-controlling interest | 32 | 35 | -8.57% |
| Total Shareholders’ Equity including non-controlling interest | 14,186 | 13,869 | +2.29% |
| Total Liabilities and Shareholders’ Equity | 25,539 | 28,723 | -11.09% |
Total Assets decreased to $25.539 billion as of December 31, 2025, compared to $28.723 billion at year-end 2024. The reduction reflected the removal of assets held for sale following the completion of the Pharma Solutions and Nitrocellulose divestitures, alongside the Food Ingredients goodwill impairment.
Total Debt fell substantially from $8.977 billion in 2024 to $5.994 billion as of December 31, 2025. Total Liabilities were reduced by $3.501 billion during 2025, closing at $11.353 billion.
- Substantial Deleveraging: The Company reduced total outstanding debt by $2.983 billion in 2025 through senior note tender repurchases, 2025 Note maturities, and full repayment of its 2026 Term Loan Facility.
- Equity Base: Total Shareholders’ Equity (including non-controlling interest) increased to $14.186 billion as of December 31, 2025, supported by positive foreign currency translation adjustments recorded in accumulated other comprehensive loss.
Cash Flow & Capital Allocation: International Flavors & Fragrances Inc. (NYSE Cash Flow Statement
Cash flows provided by operating activities totaled $850 million in 2025, compared to $1.070 billion in 2024 and $1.455 billion in 2023.
| Line Item (in $ millions) | 2025 | 2024 (Restated) | 2023 (Restated) | Latest YoY (%) |
|---|---|---|---|---|
| Net (loss) income | (359) | 267 | (2,587) | N/M |
| Depreciation and amortization | 962 | 1,015 | 1,142 | -5.22% |
| Deferred income taxes | (270) | (323) | (371) | -16.41% |
| Loss on assets classified as held for sale | 115 | 317 | 0 | -63.72% |
| Gains on sale of assets | 1 | (11) | (3) | N/M |
| Losses (Gains) on business disposals | 109 | (346) | 23 | N/M |
| Stock-based compensation | 88 | 77 | 65 | +14.29% |
| Gain on extinguishment of debt | (488) | 0 | 0 | N/M |
| Pension contributions | (29) | (29) | (36) | 0.00% |
| Pension-related (benefit) expense | (11) | 125 | (28) | N/M |
| Impairment of goodwill | 1,153 | 64 | 2,623 | +1701.56% |
| Inventory write-down | 0 | 0 | 72 | N/M |
| Change in Trade receivables | (68) | (217) | 51 | -68.66% |
| Change in Inventories | (41) | (34) | 605 | +20.59% |
| Change in Accounts payable | (57) | 40 | (39) | N/M |
| Change in Accruals for incentive compensation | (106) | 190 | (2) | N/M |
| Change in Other assets/liabilities, net | (149) | (65) | (60) | +129.23% |
| Net cash provided by operating activities | 850 | 1,070 | 1,455 | -20.56% |
| Additions to property, plant and equipment | (594) | (463) | (503) | +28.29% |
| Additions to intangible assets | (2) | (5) | 0 | -60.00% |
| Proceeds from disposal of assets | 21 | 21 | 27 | 0.00% |
| Net proceeds received from business disposals | 2,743 | 875 | 1,050 | +213.49% |
| Cash received (paid) on foreign currency forward contracts | 105 | (102) | (16) | N/M |
| Joint venture capital contributions | (4) | 0 | 0 | N/M |
| Net cash provided by investing activities | 2,269 | 326 | 558 | +596.01% |
| Cash dividends paid to shareholders | (409) | (514) | (826) | -20.43% |
| Dividends paid to redeemable non-controlling interests | 0 | 0 | (13) | N/M |
| Decrease in revolving credit facility and short term borrowings | 0 | 0 | (99) | N/M |
| Net borrowings (repayments) of commercial paper (maturities less than three months) | 314 | 0 | (187) | N/M |
| Principal payments of debt | (2,913) | (1,030) | (655) | +182.82% |
| Purchases of redeemable non-controlling interests | 0 | 0 | (39) | N/M |
| Deferred and contingent consideration paid | 0 | (36) | (6) | -100.00% |
| Withholding tax paid on stock-based compensation | (24) | (16) | (13) | +50.00% |
| Other, net | (21) | (10) | (13) | +110.00% |
| Purchase of treasury stock | (38) | 0 | 0 | N/M |
| Net cash used in financing activities | (3,091) | (1,606) | (1,851) | +92.47% |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 91 | (54) | 21 | N/M |
| Net change in cash, cash equivalents and restricted cash | 119 | (264) | 183 | N/M |
| Cash, cash equivalents and restricted cash at beginning of year | 471 | 735 | 552 | -35.92% |
| Cash, cash equivalents and restricted cash at end of year | 590 | 471 | 735 | +25.27% |
Investing activities generated $2.269 billion in net cash during 2025, driven by $2.743 billion in net proceeds from business divestitures. Outflows included $(594) million in capital expenditures (additions to property, plant and equipment).
Financing activities used $(3.091) billion in net cash during 2025. Primary financing cash uses included $(2.913) billion in debt principal repayments and $(409) million in cash dividends paid to shareholders.
Funding the Future: R&D and Expansion Spending
International Flavors & Fragrances invests substantial capital into research, creative development, scientific innovation, and facility infrastructure.
- R&D Expenditure: In 2025, research and development expenses rose to $694 million (6.4% of net sales), up from $671 million (5.8% of sales) in 2024 and $636 million (5.5% of sales) in 2023.
- R&D Personnel: The Company employs approximately 3,000 scientists, perfumers, flavorists, application technical specialists, and creators globally.
- Capital Expenditures: Capital investments in property, plant and equipment reached $594 million in 2025, compared to $463 million in 2024 and $503 million in 2023. Management expects 2026 capital spending to equal approximately 6% of sales.
4. The Corporate Family Tree: International Flavors & Fragrances Inc. (NYSE Subsidiaries & Acquisitions
Subsidiaries, Associates, & Shared Ventures
The Company maintains a consolidated network of legal entities across North America, Europe, Asia-Pacific, and Latin America. Major subsidiaries identified across corporate reporting filings include:
- Nutrition & Biosciences, Inc.: Primary operating subsidiary housing biosciences, enzymes, cultures, and specialized health ingredient assets.
- Frutarom Industries Ltd.: Israel-based international holding entity operating global taste, extract, and specialty ingredient manufacturing facilities.
- Solae, LLC: Delaware-based manufacturing operating entity providing specialized soy protein formulations and ingredients.
- Neptune Merger Sub Entities: Holding structures established during corporate combinations.
Strategic Investments & Minority Stakes
The Company holds minority equity method investments valued at $15 million as of December 31, 2025, presented within Other assets on the Consolidated Balance Sheets. Additionally, non-controlling interests in consolidated subsidiaries were $32 million at December 31, 2025.
5. Power & Control: International Flavors & Fragrances Inc. (NYSE Executive Leadership & Ownership
The Brain Trust: Board of Directors & Executive Leadership
The Executive Leadership Team directs global commercial strategy, operational execution, research programs, and administrative functions. Key executive officers as of February 27, 2026, include:
- J. Erik Fyrwald (Chief Executive Officer and Director, Age 66): Appointed Chief Executive Officer and Director in February 2024. Previously served as CEO of Syngenta (2016-2023), CEO of Univar Solutions, Chairman and CEO of Nalco, President of Ecolab, and held executive positions during a 27-year tenure at DuPont.
- Yuvraj Arora (President, Taste and Chief Commercial Officer, Age 54): Appointed Chief Commercial Officer and President, Taste in January 2025. Previously served as EVP and President, Nourish (June 2023-December 2024) and President of U.S. categories at Kellogg North America.
- Michael DeVeau (Executive Vice President, Chief Financial Officer, Age 45): Appointed Chief Financial Officer in January 2025. Joined the Company in 2009 and previously held executive roles including SVP Corporate Finance & Investor Relations, Chief Investor Relations & Communications Officer, Divisional CFO for Scent, and Head of Corporate Strategy.
- Deborah Borg (Executive Vice President, Chief People & Culture Officer, Age 49): Appointed Chief People & Culture Officer in August 2022. Previously served as Chief Human Resources and Communications Officer at Bunge Limited and held senior leadership roles at Dow Chemical.
- Ralf Finzel (Executive Vice President, Global Operations Officer, Age 62): Joined as Global Operations Officer in November 2022. Previously served as VP of Integrated Supply Chain at Honeywell International.
- Leticia Gonçalves Lourenço (President, Health & Biosciences, Age 51): Appointed President, Health & Biosciences in March 2025. Previously served as President of Precision Fermentation at ADM and spent over 25 years in senior roles at Monsanto/Bayer.
- Stephen Landsman (Executive Vice President, General Counsel, Age 66): Appointed General Counsel in July 2025. Previously served as EVP of Business Development at IFF, Group General Counsel at Syngenta, and General Counsel at Univar and Nalco Company.
- Ana Paula Teles de Mendonça (President, Scent, Age 57): Appointed President, Scent in April 2024. A 30-year veteran of IFF, previously serving as Senior Vice President of Commercial Excellence and Regional General Manager for North America Consumer Fragrances.
- Andres Muller (President, Food Ingredients, Age 61): Joined IFF in December 2024 and appointed President, Food Ingredients in January 2025. Previously served as President of Sustainable Food Solutions at Corbion and SVP Global Sales at DuPont.
- Vivek Verma (Executive Vice President, Chief Information Officer, Age 57): Appointed Chief Information Officer in February 2021. Joined IFF in 2016, following executive technology roles at American Express, GlaxoSmithKline, and PricewaterhouseCoopers.
Who Owns the Stock?
As of February 20, 2026, there were 255,477,487 shares of the Company’s common stock (par value 12 1/2¢ per share) outstanding. The aggregate market value of voting stock held by non-affiliates as of June 30, 2025, was $18,848,336,277.
On August 5, 2025, the Board of Directors authorized a $500 million share repurchase program. Between October 1, 2025, and December 31, 2025, the Company repurchased approximately 584,000 shares for $38 million.
6. Strategic Outlook: International Flavors & Fragrances Inc. (NYSE Growth Catalysts & Key Risks
Competitive Advantages & Economic Moats
The Company maintains strong competitive positioning derived from several core operational moats:
- Extensive Intellectual Property: Protected by 849 granted U.S. patents, 451 pending U.S. patent applications, thousands of international filings, and thousands of proprietary trade-secret formulas.
- Inclusion on Strategic Core Lists: Long-term commercial integration with major consumer goods multinationals that limit development bidding to preferred “core list” suppliers.
- Vertical & Global Scale: Integrated supply chain capabilities spanning 289 facilities in 30 countries, supported by proprietary biotechnology and chemical processing platforms.
What Could Go Wrong? Key Challenges & Business Risks
The Company faces several operational, regulatory, legal, and financial risks detailed in its filings:
- Antitrust Investigations & Class Action Litigation: The European Commission, UK Competition and Markets Authority, Swiss Competition Commission, and Mexican Competition Commission are investigating potential anticompetitive conduct in the fragrance industry. On February 5, 2026, the U.S. Department of Justice notified IFF that it had closed its investigation. However, multiple direct and indirect purchaser class action lawsuits remain pending in U.S. and Canadian courts. In 2025, the Company accrued a $43 million legal provision in connection with U.S. direct and indirect purchaser class actions, including a $26 million direct-purchaser settlement agreement executed in October 2025.
- Debt & Leverage Covenants: The Company maintains $5.994 billion in total debt. Credit facilities require maintenance of a maximum net debt to credit adjusted EBITDA ratio of 3.75x (with a temporary 4.25x acquisition step-up).
- Tax & N&B Indemnification Obligations: Under the Tax Matters Agreement executed with DuPont, IFF must indemnify DuPont for any tax liabilities arising from a “Spinco Tainting Act” that affects the tax-free status of the 2021 Reverse Morris Trust transaction.
- Goodwill Impairment Sensitivity: Long-lived assets include $8.269 billion in goodwill and $6.043 billion in intangibles. Future underperformance in reporting units—such as Health & Biosciences, where estimated fair value exceeded carrying value by 9% in the November 2025 annual test—could trigger non-cash impairment charges.
The Next Chapter: Growth & Expansion Initiatives
Management’s strategic transformation centers on portfolio optimization, balance sheet strengthening, and execution of the IFF Productivity Program.
- Food Ingredients Strategic Alternatives: Management continues to evaluate strategic options for the Food Ingredients segment. In August 2025, the Company agreed to sell its Soy Crush, Concentrates, and Lecithin business for $109 million in gross proceeds (expected to close by Q2 2026).
- Cost Optimization: The IFF Productivity Program targets $110 million to $130 million in total program costs through 2026 to streamline site footprints, rationalize manufacturing capacity, and reduce administrative overhead.
- Capital Allocation Priorities: Strategy prioritizes debt deleveraging to protect investment-grade credit ratings, selective growth capital expenditures (~6% of sales in 2026), sustainable dividend payments ($1.60 per share annually), and opportunistic share repurchases under the $500 million authorization.
The Verdict: Strategic Outlook & Conclusion
International Flavors & Fragrances Inc. continues to execute a multi-year corporate transformation focused on refocusing its operating footprint onto high-margin taste, scent, and bioscience markets. Through the completed divestiture of non-core assets like Pharma Solutions and Nitrocellulose, the Company generated over $2.7 billion in cash proceeds in 2025, directing capital toward substantial debt reduction and balance sheet de-risking. While the enterprise navigates ongoing regulatory investigations and non-cash goodwill adjustments, its competitive integration across global consumer supply chains, broad scientific IP, and cost productivity initiatives provide a structured operational framework for long-term stabilization.
❓ Frequently Asked Questions: International Flavors & Fragrances Inc. (NYSE
What was International Flavors & Fragrances Inc. (NYSE’s revenue and net income in FY 2025?
In FY 2025, International Flavors & Fragrances Inc. (NYSE reported total revenue of $10.89 B ((▼ 5.2%) compared to $11.48 B in the prior fiscal year). Gross profit stood at $3.94 B (gross margin of 36.16 %). Operating profit was -$382.00 M and bottom-line net income was -$359.00 M.
Is International Flavors & Fragrances Inc. (NYSE profitable and generating positive cash flow in FY 2025?
In FY 2025, International Flavors & Fragrances Inc. (NYSE reported a net loss of -$359.00 M (PAT margin: -3.30 %). On a cash basis, the company generated $850.00 M in cash flow from operating activities and invested $596.00 M in capital expenditures, resulting in free cash flow of $254.00 M. Return on Equity (ROE) was -2.54 % and Cash ROE was 6.01 %.
How much debt, assets, and equity does International Flavors & Fragrances Inc. (NYSE hold?
As of FY 2025, International Flavors & Fragrances Inc. (NYSE held $25.54 B in total assets, $11.35 B in total liabilities, and $14.15 B in total stockholders’ equity. Total debt stood at $5.99 B (debt-to-equity ratio of 0.42x). Net working capital was $1.66 B with a current ratio of 1.42x.
Who is the CEO and CFO of International Flavors & Fragrances Inc. (NYSE?
The Chief Executive Officer (CEO) of International Flavors & Fragrances Inc. (NYSE is J. Erik Fyrwald. The Chief Financial Officer (CFO) is Michael DeVeau.
Where is International Flavors & Fragrances Inc. (NYSE headquartered and when was it founded?
International Flavors & Fragrances Inc. (NYSE is headquartered in 521 West 57th Street, New York, NY 10019-2960 / 200 Powder Mill Road, Wilmington, DE 19803-2907. The company traces its founding/incorporation to New York. Total disclosed workforce/headcount is Approximately 21,500 worldwide (approximately 5,500 in the United States). Its official corporate website is https://www.iff.com.
Note: Financial ratios, margins, year-over-year (YoY) growth rates, and percentage shares of revenue are calculated by FirmsWorld based on figures reported in the company’s official SEC filing.